Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
290
datasets available to search
ShareScore release 0.9.0
Dataset results
290 results for “Dyslipidemia”
A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia
ClinicalTrials.gov study NCT00491530. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of AZD8233 in Participants With Dyslipidemia
ClinicalTrials.gov study NCT04641299. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia
ClinicalTrials.gov study NCT00463606. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
ClinicalTrials.gov study NCT00325780. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia
ClinicalTrials.gov study NCT01420549. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia
ClinicalTrials.gov study NCT01854918. IPD Sharing: Not stated. Countries: 25. Publications: 5.
Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors
ClinicalTrials.gov study NCT00928889. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
ClinicalTrials.gov study NCT02642159. IPD Sharing: Not stated. Countries: 15. Publications: 5.
Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.
ClinicalTrials.gov study NCT00770653. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of LY3561774 in Participants With Mixed Dyslipidemia
ClinicalTrials.gov study NCT05256654. IPD Sharing: YES. Countries: 7. Publications: 1.
Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
ClinicalTrials.gov study NCT00246376. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors
ClinicalTrials.gov study NCT00344175. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan
ClinicalTrials.gov study NCT06925100. IPD Sharing: YES. Countries: 1. Publications: 0.
Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia
ClinicalTrials.gov study NCT01256476. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Relative abundance tables for bacterial species, pathways, ARGs, and VFGs in "Gut Microbial Community Structure, Metabolic Signature, and Resistome in Dyslipidemia: Insights from Metagenomic Sequencing"
<p>Dyslipidemia, characterized by abnormal blood lipid levels, is a significant risk factor for cardiovascular disease. Emerging evidence suggests that the gut microbiota plays a role in lipid metabolism, although findings across studies have varied. In this study, we analyzed the gut microbiota, metabolic pathways, predicted gut metabolites, and resistome in 1384 participants (895 with dyslipidemia cases and 489 controls) using shotgun metagenomic sequencing. Our results revealed that Bacteroides caccae was enriched in dyslipidemia cases, potentially contributing to inflammation and altered lipid metabolism, while Coprococcus eutactus and Coprococcus catus, known producers of short-chain fatty acids (SCFAs) in lipid regulation, and Blautia obeum, known to be positively impacted by SCFAs, were more abundant in controls. We also identified an enrichment of the dTDP-beta-D-fucofuranose biosynthesis pathway gene family, which is linked to bacterial pathogenicity, in dyslipidemia cases, with Bacteroides stercoris contributing strongly. Dyslipidemia cases exhibited depleted glycogen and peptidoglycan biosynthesis pathways, potentially impairing energy storage and immune function, alongside distinct metabolic profiles, including decreased pseudouridine, which may affect RNA metabolism. Furthermore, we observed a higher abundance of antibiotic-resistance genes, particularly tetQ, in dyslipidemia cases, suggesting a link between gut resistome and metabolic disorders. These findings provide new insights into how dysbiosis of the gut microbiota may contribute to the pathophysiology of dyslipidemia, offering potential avenues for microbiome-based interventions in personalized medicine.</p>
Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia
ClinicalTrials.gov study NCT03156842. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human Immunoresistance
ClinicalTrials.gov study NCT00422006. IPD Sharing: Not stated. Countries: 1. Publications: 1.
From Known to New Genes in Dyslipidemia
ClinicalTrials.gov study NCT03939039. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effectiveness of Food-Based Recommendations for Minangkabau Women of Reproductive Age With Dyslipidemia
ClinicalTrials.gov study NCT04085874. IPD Sharing: NO. Countries: 1. Publications: 1.
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)
ClinicalTrials.gov study NCT03606824. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.